Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 127 items

Long-term cardiac safety analysis of NCCTG (Alliance) N9831 adjuvant trastuzumab (H) trial.

Advani, Pooja Prem , Ballman, Karla V. , Dockter, Travis J. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Long-Term-Followup - Breast - N9831

Management of Recurrent Prostate Cancer after Radiotherapy: Long-term results from CALGB 9687, a Contemporary Prospective Multi-institutional Salvage Prostatectomy Series

Al-Daghmin, A , Sokoloff, MH , Halabi, S , Sanford, BL , Eastham, JA ... - AUA - J Urology - 2014

Abstract - Primary - Long-Term-Followup - GU - CALGB-9687

SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome

Alachkar, Houda , Santhanam, Ramasamy , Maharry, Kati ... - - J. Clin. Invest - 2014

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-19808 , CALGB-9621

Exploring the statistical and clinical impact of two interim analyses on the phase II design with option for direct assignment

An, Ming-Wen , Mandrekar, Sumithra J. , Edelman, Martin J. ... - - Contemp Clin Trials - 2014

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-30203

Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance)

Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T , Gill, Paula ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - N10C1

Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)

Barton, Debra L. , Thanarajasingam, Gita , Sloan, Jeff A. ... - - Cancer - 2014

Manuscript - Primary - Primary - Symptom Inter - N08C3

Addressing the Complexities of Sexual Health in Female Cancer Survivors: NCCTG N10C1 (Alliance)

Barton, Debra , Dockter, Travis , Atherton, Pamela , Lester, Joanne ... - CANS - - 2014

Abstract - Secondary - Primary - Symptom Inter - N10C1

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8

Becker, Heiko , Maharry, Kati , Mrózek, Krzysztof , Volinia, Stefano ... - - Leukemia - 2014

Manuscript - Secondary - Primary - Leuk Corr Sci - C8525 , CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-8923 , CALGB-9022 , CALGB-9222 , CALGB-9420 , CALGB-9621 , CALGB-9720

Effect of Age on the Pharmacokinetics of Busulfan in Patients Undergoing Hematopoietic Cell Transplantation; an Alliance study (CALGB 10503, 19808, and 100103)

Beumer, Jan H. , Owzar, Kouros , Lewis, Lionel D. , Jiang, Chen ... - - Cancer Chemother. Pharmacol. - 2014

Manuscript - Secondary - Primary - PPP - C19808 , CALGB-100103 , CALGB-10503

Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy

Beutler, Andreas S. , Kulkarni, Amit A. , Kanwar, Rahul ... - - Ann. Neurol. - 2014

Manuscript - Secondary-not-in-original - Meta-Analysis - Symptom Inter - N08C1 , N08CA

Axillary Ultrasound after Neoadjuvant Chemotherapy in Patients Presenting with Node-Positive Breast Cancer (T0-T4, N1-2, M0) and its Impact on Sentinel Lymph Node Surgery in ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla , Hunt, Kelly K. , McCall, Linda M. ... - SIS - Journal of the Senologic International Society - 2014

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial

Boughey, Judy C. , McCall, Linda M. , Ballman, Karla V. ... - - Ann. Surg. - 2014

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance)

Burstein, Harold J. , Cirrincione, Constance T. , Barry, William T. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Breast - CALGB-40302

Gene expression signatures in pre- and post-therapy (Rx) specimens from CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer (BrCa).

Carey, Lisa A. , Barry, William Thomas , Pitcher, Brandy ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary - Primary - Breast - CALGB-40601

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

Cheng, H , Ballman, K , Vassilakopoulou, M , Dueck, A C ... - - Br. J. Cancer - 2014

Manuscript - Secondary - Primary - Breast - N9831

Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)

Chhibber, Aparna , Mefford, Joel , Stahl, Eli A. ... - - Pharmacogenomics J. - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Methodological Considerations in the Design and Implementation of Clinical Trials

Cirrincione, Constance T. , Lavoie Smith, Ellen M. ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - Pilot

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657)

Clark, Amy S , Chen, Jinbo , Kapoor, Shiv , Friedman, Claire ... - - Cancer Med - 2014

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

Corless, Christopher L. , Ballman, Karla V. , Antonescu, Cristina R. ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - GI - ACOSOG-Z9001

Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

Cureton, Elizabeth L. , Yau, Christina , Alvarado, Michael D. ... - - Ann. Surg. Oncol. - 2014

Manuscript - Secondary - Primary - Breast - CALGB-150007

Alliance A091103: A multicenter phase II study of the angiopoietin-1 and -2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS).

D'Angelo, Sandra P. , Mahoney, Michelle R. , Van Tine, Brian Andrew ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Experimental - A091103

Clinical impact of ABL1 kinase and IKZF1 mutations in adults with Philadelphia chromosome-positive (PH+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB 10001 and 9665 (Alliance)

DeBoer, Rebecca , Mulkey, Flora , Koval, Gregory , Wetzler, Meir ... - EHA - Haematologica - 2014

Abstract - Secondary - Primary - Leuk Corr Sci - CALGB-10001 , CALGB-9665

Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes with Bendamustine to Induce CLL Apoptosis

Ding, Wei , Shanafelt, Tait D. , Lesnick, Connie E. ... - - Br. J. Haematol. - 2014

Manuscript - Primary - Primary - Leukemia - N1087

Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma

Dronca, Roxana S. , Allred, Jacob B. , Perez, Domingo G. ... - - Am. J. Clin. Oncol. - 2014

Manuscript - Primary - Primary - Experimental - NCCTG-N0675

CALGB 150905 (Alliance): Rituximab broadens the anti-lymphoma response by activating unlicensed NK cells

Du, Juan , Lopez-Verges, Sandra , Pitcher, Brandelyn N. ... - - Cancer Immunol Res - 2014

Manuscript - Primary - Primary - Lymphoma - CALGB-150905 , CALGB-50402 , CALGB-50701

Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).

Dueck, Amylou C. , Hillman, David W. , Kottschade, Lisa A. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - Breast - N063D

NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status

Dy, Grace K. , Molina, Julian R. , Qi, Yingwei , Ansari, Rafat ... - - J Thorac Oncol - 2014

Manuscript - Primary - Primary - Respiratory - NCCTG-N0821

Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901

Faul, Leigh Anne , Luta, Gheorghe , Sheppard, Vanessa ... - - J Cancer Surviv - 2014

Manuscript - Secondary - Primary - Older Adult - CALGB-369901

Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell Lung Cancer

Fernando, Hiran C. , Landreneau, Rodney J. , Mandrekar, Sumithra J. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Respiratory - ACOSOG-Z4032

Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)

Fuchs, Michael A. , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - PLoS ONE - 2014

Manuscript - Secondary - Primary - GI - CALGB-89803

Phase II trial of vorinostat (VOR) combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (Alliance N0874/ABTC-0902)

Galanis, Evanthia , Anderson, S. Keith , Miller, C. Ryan ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Neuro-Onc - N0874

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

Garzon, Ramiro , Volinia, Stefano , Papaioannou, Dimitrios ... - - Proc. Natl. Acad. Sci. U.S.A - 2014

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-20202

Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies

Goetz, Matthew P. , Sun, James X. , Suman, Vera J. , Silva, Grace O. ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - NCCTG-89-30-52

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147

Gonsalves, Wilson I. , Mahoney, Michelle R. , Sargent, Daniel J. ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary - Primary - Correl Sci NOS - N0147

Accuracy of FDG-PET within the clinical practice of the ACOSOG Z4031 trial to diagnose clinical stage I NSCLC

Grogan, Eric L. , Deppen, Stephen A. , Ballman, Karla V. ... - - Ann. Thorac. Surg. - 2014

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4031

The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials.

Halabi, Susan , Kelly, William Kevin , Zhou, Haojin ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Meta-Analysis - GU - CALGB-90401 , S9916

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

Halabi, Susan , Lin, Chen-Yen , Kelly, W. Kevin , Fizazi, Karim S. ... - - J. Clin. Oncol - 2014

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90401

Progression-Free Survival (PFS) as a Surrogate Endpoint of Overall Survival (OS) in Patients with Metastatic Renal Cell Carcinoma (mRCC)

Halabi, Susan , Rini, Brian , Escudier, Bernard , Stadler, Walter M. ... - - Cancer - 2014

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90206

Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).

Haluska, Paul , Bernath, Albert M. , Ballman, Karla V. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Breast - N0733

Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance).

Hatch, Ace Joseph , Pang, Herbert , Starr, Mark D. , Brady, John C. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - GI - CALGB-80203

Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML

Havelange, Violaine , Ranganathan, Parvathi , Geyer, Susan ... - - Blood - 2014

Manuscript - Secondary - Primary - Leuk Corr Sci - C8525 , C9720 , CALGB-10201 , CALGB-8923 , CALGB-9420

A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Heist, Rebecca S. , Wang, Xiaofei , Hodgson, Lydia ... - - J Thorac Oncol - 2014

Manuscript - Primary - Primary - Respiratory - CALGB-30704

A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance).

Hertz, Daniel Louis , Jiang, Chen , Owzar, Kouros , Halabi, Susan ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - PPP - CALGB-60404 , CALGB-90401

Public Health and Cooperative Group Partnership: A Colorectal Cancer Educational Intervention for Breast Cancer Survivors

Homan ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - A21_011

Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

Huang, Jocelin , Nair, Suresh G. , Mahoney, Michelle R. ... - - Clin Colorectal Cancer - 2014

Manuscript - Primary - Other - GI - NCCTG-N0147

Impact of Tumor-Infiltrating B-Cell Clonal Diversity on Response to Neoadjuvant Therapy in Triple Negative and HER2+ Breast Cancer Treated on CALGB (Alliance) 40601 and 40603

Iglesia, Michael D. , Vincent, Benjamin G. , Serody, Jonathan S. ... - SABCS - Cancer Res. - 2014

Abstract - Secondary - Meta-Analysis - Breast - CALGB-40601 , CALGB-40603

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

Inwards, D J , Fishkin, P A , LaPlant, B R , Drake, M T , Kurtin, P J ... - - Ann. Oncol. - 2014

Manuscript - Primary - Primary - Lymphoma - N078D

Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial

Jagsi, Reshma , Chadha, Manjeet , Moni, Janaki , Ballman, Karla ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0011

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

Joensuu, Heikki , Eriksson, Mikael , Hall, Kirsten Sundby ... - - Cancer - 2014

Manuscript - Secondary-not-in-original - Primary - GI - ACOSOG-Z9001

Regional Differences In Breast Cancer Biomarkers In American Indian And Alaska Native Women

Kaur, Judith S , Vierkant, Robert A. , Hobday, Timothy ... - - Cancer Epidemiol. Biomarkers Prev. - 2014

Manuscript - Primary - Primary - Disparities - NCCTG-97-95-51

Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)

Klepin, Heidi D. , Pitcher, Brandelyn N. , Ballman, Karla V. ... - - J Oncol Pract - 2014

Manuscript - Secondary - Primary - Older Adult - CALGB-361004 , CALGB-49907

Feasibility of geriatric assessment for older adults with acute myeloid leukemia (AML) receiving intensive chemotherapy on a cooperative group trial: CALGB 361006 (Alliance).

Klepin, Heidi D. , Ritchie, Ellen K. , Sanford, Ben L. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Older Adult - CALGB-361006

Nursing contributions in Community Clinical Oncology Research Programs.

Klinger, Kathy , Figueras, Cesar , Beney, Kathleen M , Armer, Jane M ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - No Study Assigned

Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206

Kluger, Harriet M. , Halabi, Susan , Solomon, Nicole C ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90206

Recombinant Interleukin-2 in Patients Aged Younger Than 60 Years With Acute Myeloid Leukemia in First Complete Remission

Kolitz, Jonathan E. , George, Stephen L. , Benson, Don M. ... - - Cancer - 2014

Manuscript - Primary - Long-Term-Followup - Leukemia - CALGB-19808

Nursing's presence in the changing cooperative group setting.

Kottschade, Lisa A , Bell, Jennifer , Klinger, Kathy ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - No Study Assigned

A Comparison of Outcomes between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance)

Kutny, Matthew A. , Geyer, Susan , Laumann, Kristina M ... - ASH - Blood - 2014

Abstract - Secondary-not-in-original - Primary - Leukemia - C9710

Effect of young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance)

Kutny, Matthew A. , Gregory, John , Geyer, Susan , Laumann, Kristina ... - ASH - Blood - 2014

Abstract - Secondary-not-in-original - Primary - Leukemia - C9710

Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens

Lamont, E. B. ... - - Med Care - 2014

Manuscript - Secondary-not-in-original - Primary - Health Outcome - CALGB-9344 , CALGB-9730 , CALGB-9235 , CALGB-9732 , CALGB-80203 , CALGB-89803

Generalizability of Trial Results to Elderly Medicare Patients with Advanced Solid Tumors (Alliance 70802)

Lamont, Elizabeth B. , Schilsky, Richard L. , He, Yulei , Muss, Hyman ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary - Primary - Health Outcome - CALGB-70802

Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802)

Lamont, Elizabeth B. , Yu, Menggang , He, Yulei , Saltz, Leonard ... - - J Geriatr Oncol - 2014

Manuscript - Secondary - Primary - Health Outcome - CALGB-70802

NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study

Leal, Alexis D. , Qin, Rui , Atherton, Pamela J. , Haluska, Paul ... - - Cancer - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CA

DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147)

Lee, Adam M. , Shi, Qian , Pavey, Emily , Alberts, Steven R. ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - NCCTG-N0147

Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])

Leenstra, James L. , Miller, Robert C. , Qin, Rui ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N09C6

CALGB/SWOG 80405: PHASE III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with expanded RAS analyses untreated metastatic adenocarcinoma of the colon

Lenz, H. , Niedzwiecki, D. , Innocenti, F. , Blanke, C. , Mahoney, M. ... - ESMO - Ann. Oncol. - 2014

Abstract - Primary - Primary - GI - C80405

A mentored cooperative group pilot study: atrophic vaginitis.

Lester, Joanne L , Jarvis, Chandler , Bartholomew, Deborah ... - - Semin Oncol Nurs - 2014

Manuscript - Secondary-not-in-original - Primary - Onc Nursing - NCT02150525

The nurse liaison role in the cooperative group setting.

Levy, Sharon , Klinger, Kathy , Galinsky, Ilene , DeKrey, Wanda ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - No Study Assigned

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).

Lockhart, A C , Reed, C E , Decker, P A , Meyers, B F , Ferguson, M K ... - - Ann. Oncol. - 2014

Manuscript - Primary - Primary - GI - ACOSOG-Z4051

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CB

Adding the KIT Inhibitor Dasatinib (DAS) to Chemotherapy Overcomes the Negative Impact of KIT Mutation/over-expression in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): Results from CALGB study 10801 (Alliance)

Marcucci, Guido , Geyer, Susan , Zhao, John , Caroll, Andrew J ... - ASH - Blood - 2014

Abstract - Primary - Primary - Leukemia - CALGB-10801

Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score

Marcucci, Guido , Yan, Pearlly , Maharry, Kati , Frankhouser, David ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-10201 , CALGB-9420 , CALGB-9720 , CALGB-9621 , CALGB-19808

CALGB 50803 (Alliance): A phase II trial of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma

Martin, Peter , Jung, Sin-Ho , Johnson, Jeffrey L. , Pitcher, Brandy ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Lymphoma - CALGB-50803

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

Maurer, Matthew J. , Ghesquières, Hervé , Jais, Jean-Philippe ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Lymphoma - N0489

Central Pathology Laboratory Review of HER2 and ER in Early Breast Cancer: An ALTTO Trial [BIG 2-06 / NCCTG N063D (Alliance)] Ring Study

McCullough, Ann E. , Dell'Orto, Patrizia , Reinholz, Monica M. ... - - Breast Cancer Res. Treat. - 2014

Manuscript - Secondary - Primary - Correl Sci NOS - N063D

Primary and Secondary Endpoint Analysis of N08C9 (Alliance)- A Phase III Randomized Trial of Sulfasalazine versus Placebo in the Prevention of Acute Radiation Enteritis

Miller, R. C. , Petereit, D. G. , Sloan, J. A. , Liu, H. ... - ASTRO - INT J RADIAT BIOL - 2014

Abstract - Secondary - Primary - Symptom Inter - N08C9

A phase II trial of the Src-kinase inhibitor saracatinib after 4 cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

Molina, Julian R. , Foster, Nathan R. , Reungwetwattana, Thanyanan ... - - Lung Cancer - 2014

Manuscript - Primary - Primary - Respiratory - N0621

Randomized phase II pilot study of loratadine for the prevention of bone pain caused by pegfilgrastim.

Moukharskaya, Julia , Abrams, Deborah Michelle , Khan, Farrah B. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - NCT01311336

Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer

Ng, Kimmie , Meyerhardt, Jeffrey A. , Chan, Andrew T. , Sato, Kaori ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary-not-in-original - Long-Term-Followup - Prevention - C89803

Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer

Northfelt, DW , Allred, JB , Liu, H , Hobday, TJ , Rodacker, MW ... - - Am. J. Clin. Oncol. - 2014

Manuscript - Primary - Primary - Breast - N0437

Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831

Norton, Nadine , Olson, Rebecca M. , Pegram, Mark , Tenner, Kathleen ... - - Cancer Immunol Res - 2014

Manuscript - Secondary - Primary - Breast - N9831

VATS Lobectomy Has Better Peri-operative Outcomes than Open Lobectomy: Ancillary Analysis of CALGB 140202 (Alliance)

Nwogu, C. E. , D'cunha, J. , Pang, H. , Gu, L. , Wang, X. ... - STS - - 2014

Abstract - Secondary - Primary - Respiratory - CALGB-140202

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary - Primary - Symptom Inter - N08CB

NCCTG N10C2 (Alliance): A double-blind, placebo-controlled study of magnesium supplements to reduce menopausal hot flashes

Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - N10C2

A Randomized Trial of Diet in Men with Early Stage Prostate Cancer on Active Surveillance: Rationale and Design of the Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance])

Parsons, J. Kellogg , Pierce, John P. , Mohler, James ... - - Contemp Clin Trials - 2014

Manuscript - No-Endpoint - Trial-Description-Only - Prevention - CALGB-70807

Bevacizumab (BEV) and risk of hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401 (Alliance).

Patel, Jai Narendra , Jiang, Chen , Hertz, Daniel Louis ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90401

MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial

Pavelitz, Thomas , Renfro, Lindsay , Foster, Nathan R. ... - - PLoS ONE - 2014

Manuscript - Secondary - Primary - GI - CALGB-89803

Disease-free survival (DFS) and treatment effect estimates of the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance]; N063D) in the adjuvant treatment of HER2-positive early breast cancer (EBC) patients according to hormone receptor status

Perez, Edith A. , Holmes, Eileen , Baselga, José ... - ESMO - Ann. Oncol. - 2014

Abstract - Secondary - Primary - Breast - N063D

Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

Perez, Edith A. , Romond, Edward H. , Suman, Vera J. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Meta-Analysis - Breast - N9831

Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial.

Perez, Edith A. , Thompson, E. Aubrey , Anderson, S. Keith ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - Breast - N9831

First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-positive early breast cancer (EBC).

Piccart-Gebhart, Martine J. , Holmes, Andrew Peter , Baselga, Jose ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Breast - N063D

Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype

Poiré, Xavier , Moser, Barry K. , Gallagher, Robert E. ... - - Leuk. Lymphoma - 2014

Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9710

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

Prat, A , Lluch, A , Albanell, J , Barry, W T , Fan, C , Chacón, J I ... - - Br. J. Cancer - 2014

Manuscript - Secondary - Primary - Breast - CALGB-159905 , C9741

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: Cancer and Leukemia Group B study 10002

Rizzieri, David A. , Johnson, Jeffrey L. , Byrd, John C. ... - - Br. J. Haematol. - 2014

Manuscript - Primary - Primary - Leukemia - CALGB-10002

Comparison of performance status with peak oxygen consumption in operable patients with non-small-cell lung cancer

Roman, Michael A. , Koelwyn, Graeme J. , Eves, Neil D. ... - - Respirology - 2014

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-9238

Prognostic and Predictive Biomarkers for ACT (Adjuvant Chemotherapy) in Resected Non-Small Cell Lung Cancer (R-NSCLC): LACE-Bio

Seymour, L. K. , Le Teuff, G. , Tsao, M. , Brambilla, E. ... - ESMO - Ann. Oncol. - 2014

Abstract - Secondary-not-in-original - Meta-Analysis - Respiratory - CALGB-150802 , CALGB-9633

Association study of the let-7 miRNA-complementary site variant in the 3’ untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 clinical trial)

Sha, Dan , Lee, Adam , Shi, Qian , Alberts, Steven R. ... - - Clin. Cancer Res. - 2014

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147

Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact.

Shah, Mithun Vinod , Wiktor, Anne E. , Meyer, Reid G. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - Breast - N9831

Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901

Sheppard, Vanessa B. , Faul, Leigh Anne , Luta, George ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Older Adult - CALGB-369901

CpG Island Methylator Phenotype is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage 3 Colon Cancer

Shiovitz, Stacey , Bertagnolli, Monica M. , Renfro, Lindsay A. ... - - Gastroenterology - 2014

Manuscript - Secondary - Primary - GI - CALGB-89803

Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans

Shofer, Scott , Beyea, Matthew , Li, Sufeng , Bastian, Lori A ... - - BMJ Open Respir Res - 2014

Manuscript - Primary - Primary - Prevention - NCT01038492

Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance)

Shulman, Lawrence N. , Berry, Donald A. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Breast - CALGB-40101

A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results From ACOSOG (Alliance) Z1072

Simmons, Rache , Ballman, Karla , Cox, Charles , Carp, Ned ... - ASBrS - Ann. Surg. Oncol. - 2014

Abstract - Primary - Primary - Breast - ACOSOG-Z1072

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales.

Singh, Jasvinder A , Locke, Dona E , Satele, Daniel ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Meta-Analysis - Health Outcome - NCCTG-95-20-53 , 954651 , 959204 , NCCTG-95-24-52 , NCCTG-964251 , 979202 , NCCTG-98-24-52 , NCCTG-98-72-51 , NCCTG-98-72-52 , NCCTG-959257 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Singh, Jasvinder A , Satele, Daniel , Pattabasavaiah, Suneetha ... - - Health Qual Life Outcomes - 2014

Manuscript - No-Endpoint - Meta-Analysis - Health Outcome - 954651 , NCCTG-95-20-53 , NCCTG-95-24-52 , 959204 , NCCTG-964251 , 979202 , NCCTG-97-24-51 , NCCTG-98-24-52 , NCCTG-959257 , NCCTG-98-72-51 , NCCTG-98-72-52 , NCCTG-989251 , NCCTG-969256 , NCCTG-971151 , NCCTG-979251 , NCCTG-979253

Molecular subtyping of colon cancers and distinct prognostic groups [NCCTG N0147 (Alliance)].

Sinicrope, Frank A. , Shi, Qian , Thibodeau, Stephen N. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary - Primary - Correl Sci NOS - N0147

Overall survival result and outcomes by KRAS, BRAF, and DNA mismatch repair in relation to primary tumor site in colon cancers from a randomized trial of adjuvant chemotherapy: NCCTG (Alliance) N0147.

Sinicrope, Frank A. , Yoon, Harry H. , Mahoney, Michelle R. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary - Primary - Correl Sci NOS - N0147

Combining survival and toxicity effect sizes from clinical trials into an interpretable, quality-adjusted survival effect size estimate of treatment efficacy.

Sloan, Jeff A. , Major, Brittny , Novotny, Paul J. , Grothey, Axel ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - Symptom Inter - NCCTG-89-20-52

Calibration of Quality-Adjusted Life Years for Oncology Clinical Trials

Sloan, Jeff A. , Sargent, Daniel J. , Novotny, Paul J. ... - - J Pain Symptom Manage - 2014

Manuscript - Secondary-not-in-original - Primary - Health Outcome - NCCTG-89-20-52

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Smith, Matthew R. , Halabi, Susan , Ryan, Charles J. , Hussain, Arif ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - GU - CALGB-90202

Unexpected and serious toxicity observed with combined idelalisib, lenalidomide and rituximab in relapsed/refractory B cell lymphomas: Alliance A051201 and A051202

Smith, Sonali M. , Pitcher, Brandelyn N. , Jung, Sin-Ho ... - ASH - Blood - 2014

Abstract - Secondary - Meta-Analysis - Lymphoma - A051201 , A051202

Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Switch Maintenance with Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-controlled Phase III Trial

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Favorable outcomes for adolescents and young adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early results of US Intergroup trial CALGB 10403 (Alliance)

Stock, Wendy , Luger, Selina , Advani, Anjali , Geyer, Susan ... - ASH - Blood - 2014

Abstract - Primary - Preliminary - Leukemia - CALGB-10403

Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (Alliance) trial

Su, Stacey , Scott, Walter J , Allen, Mark S , Darling, Gail E ... - - J. Thorac. Cardiovasc. Surg. - 2014

Manuscript - Secondary - Primary - Respiratory - ACOSOG-Z0030

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer?: A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab

Van Loon, Katherine , Espinoza, Anne M. , Fogelman, David R. ... - - Pancreas - 2014

Manuscript - Secondary-not-in-original - Primary - GI - N034A

25-Hydroxyvitamin D Levels and Survival in Advanced Pancreatic Cancer: Findings From CALGB 80303 (Alliance)

Van Loon, Katherine , Owzar, Kouros , Jiang, Chen , Kindler, Hedy L. ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary - Primary - GI - CALGB-151006 , CALGB-80303

CALGB/SWOG 80405: Analysis of patients undergoing surgery as part of treatment strategy

Venook, A. , Niedzwiecki, D. , Lenz, H. , Mahoney, M. , Innocenti, F. ... - ESMO - Ann. Oncol. - 2014

Abstract - Secondary - Primary - GI - CALGB-80405

CALGB/SWOG 80405: Phase III Trial of Irinotecan/5-FU/Leucovorin (FOLFIRI) or Oxaliplatin/5-FU/Leucovorin (mFOLFOX6) with Bevacizumab (BV) or Cetuximab (CET) for Patients (PTS) with KRAS Wild-Type (WT) Untreated Metastatic Adenocarcinoma of the colon

Venook, A. , Niedzwiecki, D. , Lenz, H.J. , Innocenti, F. ... - ESMO GI - Ann. Oncol. - 2014

Abstract - Primary - Primary - GI - CALGB-80405

CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).

Venook, Alan P. , Niedzwiecki, Donna , Lenz, Heinz-Josef ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - GI - CALGB-80405

CALGB 100801 (Alliance): A phase II multi-center NCI cooperative group study of the addition of azacitidine (AZA) to reduced-intensity conditioning (RIC) allogeneic transplantation for high risk myelodysplasia (MDS) and older patients with acute myeloid leukemia (AML): Results of a busulfan test dose strategy

Vij, Ravi , Hars, Vera , Shea, Thomas , Hoke, Eva , Blum, William ... - ASH - Blood - 2014

Abstract - Secondary - Primary - Transplant - CALGB-100801

Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)

Wang, Xiaofeng , Owzar, Kouros , Gupta, Pankaj , Larson, Richard A ... - - Br J Clin Pharmacol - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-10105

Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification

Wetzler, Meir , Mrózek, Krzysztof , Kohlschmidt, Jessica ... - - Haematologica - 2014

Manuscript - Secondary-not-in-original - Primary - Leuk Corr Sci - C8221 , C8525 , C9720 , CALGB-10201 , CALGB-8923

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

Wetzler, Meir , Watson, Dorothy , Stock, Wendy , Koval, Gregory ... - - Haematologica - 2014

Manuscript - Primary - Primary - Leukemia - CALGB-10001

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

Whitman, Susan P. , Kohlschmidt, Jessica , Maharry, Kati ... - - Leukemia - 2014

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-8525 , CALGB-8923 , CALGB-9420 , CALGB-9621 , CALGB-9720 , CALGB-10201 , CALGB-19808

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

Wolpin, Brian M. , Rizzato, Cosmeri , Kraft, Peter ... - - Nat. Genet. - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - C80303

Racial differences in KRAS/BRAF mutation rates and survival in colon cancer (NCCTG N0147 [Alliance]).

Yoon, Harry H. , Shi, Qian , Alberts, Steven R. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Secondary-not-in-original - Primary - GI - N0147

KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild type stage III colon cancers from an adjuvant chemotherapy trial (N0147 Alliance)

Yoon, Harry H. , Tougeron, David , Shi, Qian , Alberts, Steven R. ... - - Clin. Cancer Res. - 2014

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147